Taiyo Holdings Co Ltd (4626.T)
17 Nov 2017
Latest Key Developments (Source: Significant Developments)
Marketing and manufacturing right transfer of 13 long-term listed products from Chugai Pharmaceutical to Taiyo Pharma
Nov 14 (Reuters) - Chugai Pharmaceutical Co Ltd <4519.T>:Says it and TAIYO HOLDINGS CO LTD <<<4626.T>>> announced today that they have entered into an agreement, under which the co and F. Hoffmann-La Roche, Ltd. will transfer the marketing authorizations, including marketing and manufacturing rights, of 13 long-term listed products manufactured and marketed in Japan by Chugai to TAIYO Pharma Co., Ltd., a wholly owned subsidiary of Taiyo Holdings. Full Article
Taiyo Holdings Co Ltd <4626.T> :Says it completes 42,900 shares issuance via private placement and raises about 153.8 million yen in total, on June 27. Full Article
Taiyo Holdings Co Ltd <4626.T>:Says it to issue 42,900 class A preferred shares at 3,585 yen per share (153.8 million yen in total), through private placement to five individuals, on June 27. Full Article
ZURICH, Nov 14 Chugai Pharmaceuticals, a Japan-based Roche subsidiary, said on Tuesday it has agreed to transfer the marketing and manufacturing right of 13 long-term listed products to Taiyo Holdings' Taiyo Pharma.